Time-resolved laser-induced fluorescence spectroscopy systems and uses thereof

US2021255107A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2021255107-A1
Application numberUS-202117198816-A
CountryUS
Kind codeA1
Filing dateMar 11, 2021
Priority dateMar 15, 2013
Publication dateAug 19, 2021
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides systems for characterizing a biological sample by analyzing emission of fluorescent light from the biological sample upon excitation and methods for using the same. The system includes a laser source, collection fibers, a demultiplexer and an optical delay device. All references cited herein are incorporated by reference in their entirety as though fully set forth. Unless defined otherwise, technical and scientific terms used herein have the same meaning as commonly understood by one of-ordinary skill in the art in which this invention belongs.

First claim

Opening claim text (preview).

1 . A system for characterizing a biological sample by analyzing emission of fluorescent light from the biological sample upon excitation comprising: (a) a laser source connected to a biological sample via excitation fibers (ExF), wherein the laser is configured to irradiate the biological sample with a laser pulse at a predetermined wavelength to cause the biological sample to produce a responsive fluorescence signal; (b) a light collector, wherein the light collector collects the responsive fluorescence signal from the biological sample, and relays the fluorescence signal to a plurality of filters; and (c) the plurality of filters, each filter of the plurality of filters being configured to split the responsive fluorescence signal at pre-determined wavelengths to obtain spectral bands, wherein a first spectral band comprises wavelengths within a range of 410-450 nm, a second spectral band comprises wavelengths within a range of 450-480 nm, and a third spectral band comprises wavelengths within a range of 500-560 nm. 2 . The system of claim 1 , wherein a fourth spectral band comprises wavelengths within a range of 365-410 nm and wherein a fifth spectral band comprises wavelengths greater than 600 nm, and optionally wherein a sixth spectral band comprises wavelengths of less than 365 nm. 3 . The system of claim 1 , further comprising an optical delay device. 4 . The system of claim 3 , wherein the optical delay device is adapted to couple the spectral bands from the plurality of filters into the optical delay device, allow the spectral bands to travel through the optical delay device, and introduce a controlled time delay to the spectral bands as the spectral bands travel through the optical delay device. 5 . The system of claim 3 , wherein the optical delay device comprises a plurality of optical fibers and optionally wherein two or more of the plurality of optical fibers have different optical path lengths. 6 . The system of claim 1 , wherein the plurality of filters form a demultiplexer. 7 . The system of claim 1 , wherein the light collector comprises one or more collection fibers (CF) or lenses. 8 . A method for characterizing a biological sample by analyzing emission of a fluorescence signal from the biological sample upon excitation comprising: (a) irradiating the biological sample with a laser pulse at a predetermined wavelength to cause the biological sample to produce a responsive fluorescence signal; (b) collecting the responsive fluorescence signal from the biological sample; and (c) splitting the responsive fluorescence signal with a plurality of filters, each filter of the plurality of filters being configured to split the responsive fluorescence signal at pre-determined wavelengths to obtain spectral bands, wherein a first spectral band comprises wavelengths within a range of 410-450 nm, a second spectral band comprises wavelengths within a range of 450-480 nm, and a third spectral band comprises wavelengths within a range of 500-560 nm. 9 . The method of claim 8 , wherein a fourth spectral band comprises wavelengths within a range of 365-410 nm and wherein a fifth spectral band comprises wavelengths greater than 600 nm, and optionally wherein a sixth spectral band comprises wavelengths of less than 365 nm. 10 . The method of claim 8 , wherein the responsive fluorescence signal is emitted by a biomolecule and optionally wherein the biomolecule is any one or more of PLP-GAD (pyridoxal-5′-phosphate (PLP) glutamic acid decarboxylase (GAD)), bound NADH, free NADH, flavin mononucleotide (FMN) riboflavin, flavin adenine dinucleotide (FAD) riboflavin, lipopigments, endogenous porphyrins or a combination thereof. 11 . A method for determining tissue viability comprising analyzing emission of responsive fluorescence signals from biomolecules in the tissue by the method of claim 8 , wherein an increase in responsive fluorescence signals of the biomolecule in the biological sample relative to a normal sample is indicative of poor tissue viability. 12 . A method for continuously monitoring cellular metabolism comprising analyzing emission of a responsive fluorescence signal by the method of claim 8 . 13 . A method for determining drug or metabolite level in plasma comprising analyzing emission of a responsive fluorescence signal from a biomolecule by the method of claim 8 . 14 . The method of claim 8 , further comprising (d) passing the spectral bands through a time-delay mechanism; (e) obtaining the time-delayed spectral bands; and (f) processing the time-delayed spectral bands. 15 . The method of claim 14 , wherein processing the time-delayed spectral bands comprises detecting the time-delayed spectral bands.

Assignees

Inventors

Classifications

  • using optical fibers · CPC title

  • invasive, e.g. introduced into the body by a catheter · CPC title

  • Fluorescence spectrometry · CPC title

  • for introduction into the body, e.g. by catheters (A61B5/1459 takes precedence) · CPC title

  • Measuring fluorescence of biological material, e.g. DNA, RNA, cells (G01N21/6428 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2021255107A1 cover?
The invention provides systems for characterizing a biological sample by analyzing emission of fluorescent light from the biological sample upon excitation and methods for using the same. The system includes a laser source, collection fibers, a demultiplexer and an optical delay device. All references cited herein are incorporated by reference in their entirety as though fully set forth. Unless…
Who is the assignee on this patent?
Cedars Sinai Medical Center
What technology area does this patent fall under?
Primary CPC classification G01N21/6486. Mapped technology areas include Physics.
When was this patent published?
Publication date Thu Aug 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).